Sebaceous glands in the uterine cervix: two new cases

The authors report on two new cases of sebaceous glands in the uterine cervix. This extremely rare histological observation was found on biopsy specimens of the uterine cervix because of unclear colposcopic findings and of recurrent CIN II. The etiology of this entity is discussed including a brief review of the medical literature.     

Conization of the uterine cervix. A study of 900 cases

In the years 1968 till 1982, 900 conisations of uterine cervix were performed, 90% of which were diagnostic interventions. During the follow-up period, the mean age of the patients with carcinoma in situ decreased 4 years, the mean age from patients with microcarcinoma 3.2 years. In 64% the conisation was carried out due to a positive or suspekt smear. Conisations, performed during pregnancy, were not associated with any additional complications for mother or child. Taking a big conus resulted more often in a total extirpation of the neoplastic changes, without increasing the complication rate. The average hospital stay was 8.7 days. It was only prolonged in patients with secondary hemorrhage. 33% of all neoplastic changes were extirpated totally. In 85% of the women who had follow-up only after incomplete extirpation of the neoplasia by conisation, there was no recurrence. The rest did show the neoplasia again, often in a more serious way. The overall complication-rate was 7.4%.     

Adenocarcinoma of the uterine cervix: a study of 73 cases

Seventy-three patients with adenocarcinoma of the cervix were seen between 1969 and 1983. This represented 8.1% of all carcinoma of cervix seen during that period. Survival rates in stage Ib were significantly worse for those with poorly differentiated lesions and for those with involved pelvic lymph nodes. Age at presentation appeared to decline over the period of the study. When the patients with stage Ib lesions were compared with a group of stage Ib squamous carcinomas treated in the same unit, there was no difference in age at presentation, node metastasis rates, or survival. Four patients had cervical intraepithelial neoplasia (CIN) in addition to adenocarcinoma.     

Myoma expulsion after uterine artery embolization

Uterine artery embolization (UAE) has become a standard therapy in the treatment of symptomatic uterine myomas. The procedure is associated with a few complications. One of them is myoma expulsion. A 32-year-old woman was sent to our hospital with diagnosed intramural myoma with dysmenorrhea and pressure symptoms. UAE was performed since the patient preferred conservative treatment. The procedure was without any complications. Three weeks after embolization, she was readmitted because of vaginal discharge and minor bleeding. We diagnosed expulsion of necrotic myoma and performed transvaginal resection. Four months later, the patient is symptom free. Expulsion of intramural myoma can be thus considered as definite treatment and not a complication of embolization therapy.     

Sarcoma of the uterine cervix: clinicopathologic findings in three cases

The clinicopathologic findings in two patients with cervical stromal sarcoma and one with cervical leiomyosarcoma are presented. The patients were 35, 46, and 45 years, respectively. They presented with vaginal bleeding, vaginal discharge, and a cervical mass of less than 5 months duration. A hysterectomy with bilateral salpingo-oophorectomy was performed in each case. One patient received preoperative radiation therapy. Two patients with follow-up manifested hematogenous metastasis.     

宫颈腺癌48例临床病例分析

目的:分析宫颈腺癌的临床病理特点和预后影响因素,探讨其治疗方案。方法:回顾分析2005年1月至2015年12月天津医科大学总医院妇产科收治的48例宫颈腺癌患者的临床病理和随访资料。结果:48例患者中位年龄48.5岁(33~84岁),中位随访时间41月(3~132月)。FIGO分期:I期28例(58.3%),Ⅱ期13例(27.1%),Ⅲ期4例(8.3%),Ⅳ期3例(6.3%);阴道不规则出血27例(56.3%)。5年总生存率37.5%。淋巴结转移者的5年生存率为0(0/6),显著低于无转移者[55.17%(16/29)],差异有统计学意义(P0.05);保留卵巢患者的5年生存率为71.43%(5/7),显著高于不保留卵巢者[42.86%(12/28)](P0.05)。局部肿瘤大小(P=0.045)、淋巴结转移(P=0.000)、FIGO分期(P=0.000)、宫旁转移(P=0.043)、卵巢转移(P=0.044)均是影响复发的高危因素。多因素显示,淋巴结转移(P=0.000)和局部肿瘤大小(P=0.050)是肿瘤复发的独立危险因素。淋巴结转移与FIGO分期显著相关(P=0.000)。结论:局部肿瘤大小和淋巴结转移是影响宫颈腺癌复发的主要因素;早期宫颈腺癌患者保留卵巢不影响生存率。